TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF GLOBAL ENDOTRACHEAL AND TRACHEAL SUCTION MARKET 26
1.4 CURRENCY AND PRICING 27
1.5 LIMITATION 27
1.6 MARKETS COVERED 28
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHIC SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 RESEARCH METHODOLOGY 34
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 37
2.7 SECONDARY SOURCES 38
2.8 ASSUMPTIONS 38
3 MARKET OVERVIEW 39
3.1 DRIVERS 41
3.1.1 INCREASE IN EMERGENCY OR TRAUMA CASES 41
3.1.2 DEMAND FOR ADVANCED DEVICES 41
3.1.3 INCREASE IN COPD CASES 42
3.2 RESTRAINTS 43
3.2.1 INCREASE IN RISK OF INFECTIONS (VAP) 43
3.2.2 PRODUCT RECALL 43
3.3 OPPORTUNITIES 44
3.3.1 GROWTH POTENTIAL IN EMERGING COUNTRIES 44
3.4 CHALLENGES 45
3.4.1 HARMFUL EFFECTS OF CERTAIN DEVICES ON NEONATES 45
3.4.2 DEARTH OF SKILLED PROFESSIONALS 46
4 EXECUTIVE SUMMARY 47
5 PREMIUM INSIGHTS 51
?
6 GLOBAL ENDOTRACHEAL & TRACHEAL SUCTION MARKET, BY TYPE 54
6.1 OVERVIEW 55
6.2 CLOSED TRACHEAL SUCTION SYSTEM 56
6.3 OPEN TRACHEAL SUCTION SYSTEM 57
7 GLOBAL ENDOTRACHEAL & TRACHEAL SUCTION MARKET, BY PRODUCT TYPE 58
7.1 OVERVIEW 59
7.2 ENDOTRACHEAL SUCTION 60
7.2.1 ENDOTRACHEAL TUBE 61
7.2.2 SUCTION CATHETER 61
7.2.3 SUCTION APPARATUS 61
7.2.4 MONITORING EQUIPMENT 61
7.2.5 ENDOTRACHEAL CANNULA 61
7.2.6 OXYGEN SOURCE 61
7.2.7 OTHERS 61
7.2.7.1 DISPOSABLE GLOVES 62
7.2.7.2 DISPOSABLE PLASTIC APRON 62
7.2.7.3 GOGGLES 62
7.2.7.4 DISTILLED WATER 62
7.2.7.5 ALCOHOL HAND RUB 62
7.2.7.6 OTHERS 62
7.3 TRACHEAL SUCTION 63
7.3.1 TRACHEAL TUBE 64
7.3.2 SUCTION EQUIPMENT 64
7.3.3 SYRINGE 64
7.3.4 TRACH DRESSING 64
7.3.5 TRACHEAL CANNULA 64
7.3.6 OTHERS 64
7.3.6.1 STERILE GLOVES 65
7.3.6.2 AMBU BAG 65
7.3.6.3 STERILE WATER SOLUBLE LUBRICANT 65
7.3.6.4 STERILE TOWEL 65
7.3.6.5 OTHERS 65
8 GLOBAL ENDOTRACHEAL & TRACHEAL SUCTION MARKET, BY SUCTION TYPE 66
8.1 OVERVIEW 67
8.2 SHALLOW SUCTION 68
8.3 DEEP SUCTIONING 69
?
9 GLOBAL ENDOTRACHEAL SUCTION MARKET, BY END USER 70
9.1 OVERVIEW 71
9.2 HOSPITALS 72
9.3 HOMECARE SETTINGS 73
9.4 LONG TERM ASSISTED CARE (LTACS) 73
9.5 OUTPATIENT CLINIC 74
9.6 PHYSICIAN'S OFFICE 74
9.7 MEDICAL TRANSPORTATION 75
9.8 REHABILITATION CENTERS 75
10 GLOBAL ENDOTRACHEAL & TRACHEAL SUCTION MARKET GEOGRAPHY 76
10.1 GLOBAL 76
10.2 NORTH AMERICA 84
10.2.1 U.S. 91
10.2.2 CANADA 94
10.3 EUROPE 97
10.3.1 GERMANY 104
10.3.2 U.K. 108
10.3.3 FRANCE 111
10.3.4 SPAIN 114
10.3.5 ITALY 117
10.3.6 SWITERLAND 120
10.3.7 NETHERLANDS 124
10.3.8 TURKEY 128
10.3.9 BELGIUM 131
10.3.10 RUSSIA 134
10.3.11 REST FO EUROPE 137
10.4 ASIA-PACIFIC 138
10.4.1 JAPAN 146
10.4.2 CHINA 149
10.4.3 INDIA 152
10.4.4 SOUTH KOREA 155
10.4.5 AUSTRALIA 159
10.4.6 SINGAPORE 163
10.4.7 THAILAND 167
10.4.8 MALAYSIA 170
10.4.9 INDONESIA 174
10.4.10 PHILIPPINES 178
10.4.11 REST OF APAC 182
?
10.5 SOUTH AMERICA 183
10.5.1 BRAZIL 190
10.5.2 MEXICO 193
10.5.3 REST OF SOUTH AMERICA 196
10.6 MIDDLE EAST & AFRICA 197
10.6.1 SOUTH AFRICA 204
10.6.2 REST OF MIDDLE EAST & AFRICA 208
11 GLOBAL ENDOTRACHEAL AND TRACHEAL SUCTION MARKET, COMPANY LANDSCAPE 209
11.1 COMPANY SHARE ANALYSIS; GLOBAL 209
11.2 COMPANY SHARE ANALYSIS; NORTH AMERICA 210
11.3 COMPANY SHARE ANALYSIS; EUROPE 211
11.4 COMPANY SHARE ANALYSIS; ASIA-PACIFIC 212
12 COMPANY PROFILE 213
12.1 MEDTRONIC 213
12.1.1 COMPANY OVERVIEW 213
12.1.2 MEDTRONIC; REVENUE ANALYSIS (2017) 213
12.1.3 COMPANY SHARE ANALYSIS; 214
12.1.4 PRODUCT PORTFOLIO 214
12.1.5 RECENT DEVELOPMENTS 216
12.2 TELEFLEX INCORPORATED 217
12.2.1 COMPANY OVERVIEW 217
12.2.2 REVENUE ANALYSIS (2017) 217
12.2.3 COMPANY SHARE ANALYSIS; 218
12.2.4 PRODUCT PORTFOLIO 218
12.2.5 RECENT DEVELOPMENTS 219
12.3 SMITHS MEDICAL 220
12.3.1 COMPANY OVERVIEW 220
12.3.2 GEOGRAPHICAL PRESENCE 220
12.3.3 COMPANY SHARE ANALYSIS; 221
12.3.4 PRODUCT PORTFOLIO 221
12.3.5 RECENT DEVELOPMENTS 222
12.4 ATPL 223
12.4.1 COMPANY OVERVIEW 223
12.4.2 GEOGRAPHICAL PRESENCE 223
12.4.3 PRODUCT PORTFOLIO 224
12.4.4 RECENT DEVELOPMENTS 224
?
12.5 BD. 225
12.5.1 COMPANY OVERVIEW 225
12.5.2 REVENUE ANALYSIS (2017) 225
12.5.3 PRODUCT PORTFOLIO 226
12.5.4 RECENT DEVELOPMENTS 226
12.6 CARDIOMED SUPPLIES INC. 227
12.6.1 COMPANY OVERVIEW 227
12.6.2 PRODUCT PORTFOLIO 227
12.6.3 RECENT DEVELOPMENTS 227
12.7 ENDOCLEAR LLC 228
12.7.1 COMPANY OVERVIEW 228
12.7.2 PRODUCT PORTFOLIO 228
12.7.3 RECENT DEVELOPMENTS 228
12.8 FLEXICARE MEDICAL LIMITED. 229
12.8.1 COMPANY OVERVIEW 229
12.8.2 GEOGRAPHICAL PRESENCE 229
12.8.3 PRODUCT PORTFOLIO 230
12.8.4 RECENT DEVELOPMENTS 230
12.9 HALYARD HEALTH, INC. 231
12.9.1 COMPANY OVERVIEW 231
12.9.2 REVENUE ANALYSIS (2017) 231
12.9.3 PRODUCT PORTFOLIO 232
12.9.4 RECENT DEVELOPMENTS 232
12.10 HUM GESELLSCHAFT F?R HOMECARE UND MEDIZINTECHNIK MBH 233
12.10.1 COMPANY OVERVIEW 233
12.10.2 PRODUCT PORTFOLIO 233
12.10.3 RECENT DEVELOPMENTS 233
12.11 INTERSURGICAL LTD 234
12.11.1 COMPANY OVERVIEW 234
12.11.2 GEOGRAPHICAL PRESENCE 234
12.11.3 PRODUCT PORTFOLIO 235
12.11.4 RECENT DEVELOPMENTS 235
12.12 NUVASIVE, INC. 236
12.12.1 COMPANY OVERVIEW 236
12.12.2 REVENUE ANALYSIS (2017) 236
12.12.3 PRODUCT PORTFOLIO 237
12.12.4 RECENT DEVELOPMENTS 237
?
12.13 OSCAR BOSCAROL S.R.L. 238
12.13.1 COMPANY OVERVIEW 238
12.13.2 GEOGRAPHICAL PRESENCE 238
12.13.3 PRODUCT PORTFOLIO 239
12.13.4 RECENT DEVELOPMENTS 239
12.14 STEVE SHANDONG MEDICAL SCIENCE & TECHNOLOGY CO., LTD. 240
12.14.1 COMPANY OVERVIEW 240
12.14.2 PRODUCT PORTFOLIO 240
12.14.3 RECENT DEVELOPMENTS 240
12.15 TROGE MEDICAL GMBH 241
12.15.1 COMPANY OVERVIEW 241
12.15.2 PRODUCT PORTFOLIO 241
12.15.3 RECENT DEVELOPMENTS 242
12.16 VITALTEC CORPORATION. 243
12.16.1 COMPANY OVERVIEW 243
12.16.2 PRODUCT PORTFOLIO 243
12.16.3 RECENT DEVELOPMENTS 244
12.17 VYAIRE 244
12.17.1 COMPANY OVERVIEW 244
12.17.2 GEOGRAPHICAL PRESENCE 244
12.17.3 PRODUCT PORTFOLIO 245
12.17.4 RECENT DEVELOPMENTS 245
12.18 VYGON 246
12.18.1 COMPANY OVERVIEW 246
12.18.2 GEOGRAPHICAL PRESENCE 246
12.18.3 PRODUCT PORTFOLIO 247
12.18.4 RECENT DEVELOPMENTS 247
13 RELATED REPORTS 248